Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.
Clinical trial NCT03028909 · WITHDRAWN
Trial details
- NCT number
- NCT03028909
- Sponsor
- MedImmune LLC
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-24
- Primary completion
- 2019-07-26
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.